ASIA-PACIFIC BIOSURGERY MARKET 2019-2027

MARKET OUTLOOK
The Asia Pacific biosurgery market is increasing at an estimated CAGR of 9.79% over the projected years.
China, India, Japan, South Korea, ASEAN countries, Australia & New Zealand and countries in rest of APAC together constitute the market for biosurgery in the Asia-Pacific region. The APAC region is the fastest-growing region in the overall biosurgery market. The estimated high rate of growth is primarily attributable to a vast patient pool, rise in chronic disorders and an aging populace.
Medical technology has seen recent advancements in India, and the use of advanced bio surgical products in India has increased significantly. Biosurgery products have become indispensable elements in any operating room environment. Increasing rates of chronic disorders in India and government funding to promote advanced medical technology are likely to drive market growth during the forecast period. Increasing government investment in the medical sector to improve public health and to equip the healthcare sector with advanced medical technologies is expected to drive the biosurgery market growth in India during the analysis period.
Increasing chronic disorders and the aging population are the major drivers of the growth of the market in China. Chronic disorders including heart diseases, respiratory diseases, and renal disorders are highly prevalent in China. This factor is responsible for the increase in the surgery rate in China. China’s aging population is increasing rapidly and this has put immense stress on the country’s rising economy over the past three decades. This factor is likely to drive the demand for surgery in the future, stimulating the demand for highly advanced surgical methodologies such as biosurgery.


COMPETITIVE OUTLOOK
The top giants in the biosurgery market are Johnson & Johnson, Baxter International, Inc., Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, Olympus Corporation, Medtronic Plc, RTI Surgical, Stryker Corporation, Wright Medical Group N.V., Sanofi, Ypsomed Holding AG, Ethicon, Inc. and Smith & Nephew Plc.

TABLE OF CONTENTS
1. BIOSURGERY MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. TRENDS IN BIOSURGERY TECHNOLOGY
2.3. REGULATORY FRAMEWORK
2.4. KEY VENDORS OUTLOOK
2.5. KEY INSIGHT
2.6. KEY BUYING OUTLOOK
2.7. KEY PATENT OUTLOOK
2.8. MARKET DRIVERS
2.8.1. SURGE IN SURGICAL TREATMENTS FOR MUSCULOSKELETAL DISORDERS
2.8.2. RISE IN SPINAL FUSION AND JOINT RECONSTRUCTION
2.8.3. INCREASING TRAUMA-RELATED WOUNDS
2.9. MARKET RESTRAINTS
2.9.1. STRINGENT REGULATORY APPROVAL
2.9.2. INCREASE IN THE COST OF SURGERIES
2.9.3. INCREASING USAGE OF MINIMALLY INVASIVE SURGERIES
2.9.4. LACK OF AWARENESS
2.10. MARKET OPPORTUNITIES
2.10.1. DEVELOPMENT OF POLICY FOR REIMBURSEMENT AND COMPENSATION
2.10.2. INCREASE IN RESEARCH AND INVESTMENT IN BIOENGINEERING
2.11. MARKET CHALLENGES
2.11.1. AMPLIFIED SCRUTINY OF STEM CELL-DERIVED PRODUCTS
2.11.2. COMPLICATION RELATED TO IMMUNE RESPONSE
2.11.3. LACK OF SIGNIFICANT DIFFERENTIATION IN THE RANGE OF PRODUCTS
2.11.4. PRODUCT SIDE-EFFECTS AND FDA INQUIRY
3. BIOSURGERY MARKET OUTLOOK - BY PRODUCT
3.1. BONE-GRAFT SUBSTITUTES
3.1.1. SYNTHETIC GRAFT EXTENDER
3.1.2. DEMINERALIZED BONE MATRIX
3.1.3. BONE MORPHOGENETIC PROTEINS
3.1.4. CELL-BASED MATRICES
3.2. HEMOSTATIC AGENTS
3.3. SOFT-TISSUE MANAGEMENT
3.3.1. SYNTHETIC MESH/PATCH
3.3.2. NATURAL MESH/PATCH
3.4. SURGICAL SEALING AGENTS
3.4.1. NATURAL SURGICAL SEALING AGENTS
3.4.2. SYNTHETIC SURGICAL SEALING AGENTS
3.5. ANTI-ADHESIVE AGENTS
4. BIOSURGERY MARKET OUTLOOK - BY APPLICATION
4.1. NEURO AND SPINE SURGERY
4.2. CARDIO AND THORACIC SURGERY
4.3. GENERAL SURGERY
4.4. ORTHOPEDIC SURGERY
5. BIOSURGERY MARKET OUTLOOK - BY SOURCE TYPE
5.1. NATURAL
5.2. SYNTHETIC
6. BIOSURGERY MARKET - REGIONAL OUTLOOK
6.1. ASIA-PACIFIC
6.1.1. COUNTRY ANALYSIS
6.1.1.1. CHINA
6.1.1.2. JAPAN
6.1.1.3. INDIA
6.1.1.4. AUSTRALIA
6.1.1.5. REST OF ASIA-PACIFIC
7. COMPETITIVE LANDSCAPE
7.1. B. BRAUN MELSUNGEN AG
7.2. JOHNSON & JOHNSON
7.3. BAXTER INTERNATIONAL, INC.
7.4. ETHICON, INC.
7.5. MEDTRONIC PLC
7.6. SANOFI
7.7. OLYMPUS CORPORATION
7.8. RTI SURGICAL
7.9. SMITH & NEPHEW PLC
7.10. STRYKER CORPORATION
7.11. ZIMMER BIOMET HOLDINGS, INC.
7.12. WRIGHT MEDICAL GROUP N.V.
7.13. YPSOMED HOLDING AG
8. METHODOLOGY AND SCOPE
8.1. RESEARCH SCOPE
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY


TABLE LIST
TABLE 1 ASIA-PACIFIC BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
TABLE 2 MEDICAL DEVICE CLASSIFICATION
TABLE 3 TYPES OF PMA SUPPLEMENTS
TABLE 4 MEDICAL DEVICES BY CLASS
TABLE 5 RULES AND REGULATIONS IN JAPAN
TABLE 6 ASIA-PACIFIC BIOSURGERY MARKET BY PRODUCTS 2019-2027 (IN $ MILLION)
TABLE 7 DIFFERENT TYPES OF BONE-GRAFT SUBSTITUTES
TABLE 8 ASIA-PACIFIC BIOSURGERY MARKET IN BONE-GRAFT SUBSTITUTES BY TYPES 2019-2027 (IN $ MILLION)
TABLE 9 KEY SOFT TISSUE-MANAGEMENT PRODUCTS AVAILABLE IN THE MARKET
TABLE 10 ASIA-PACIFIC BIOSURGERY MARKET IN SOFT-TISSUE MANAGEMENT BY TYPES 2019-2027 (IN $ MILLION)
TABLE 11 KEY SURGICAL SEALING AGENTS AVAILABLE IN THE MARKET
TABLE 12 ASIA-PACIFIC BIOSURGERY MARKET BY APPLICATIONS 2019-2027 (IN $ MILLION)
TABLE 13 TYPES OF CARDIOVASCULAR DISEASES
TABLE 14 STAGES OF GRAFT HEALING AND THEIR CHARACTERISTICS
TABLE 15 ASIA-PACIFIC BIOSURGERY MARKET BY SOURCE TYPE 2019-2027 (IN $ MILLION)
TABLE 16 ASIA-PACIFIC BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)


FIGURE LIST
FIGURE 1 ASIA-PACIFIC BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 2 KEY STRATEGIES IN BIOSURGERY MARKET
FIGURE 3 JAPAN PATENT ANALYSIS BY PRODUCT 2010-2016
FIGURE 4 JAPAN PATENT ANALYSIS BY MARKET PARTICIPANT 2010-2016
FIGURE 5 CHINA PATENT ANALYSIS BY PRODUCT 2010-2016
FIGURE 6 CHINA PATENT ANALYSIS BY MARKET PARTICIPANT 2010-2016
FIGURE 7 KOREA PATENT ANALYSIS BY PRODUCT 2010-2016
FIGURE 8 KOREA PATENT ANALYSIS BY MARKET PARTICIPANT 2010-2016
FIGURE 9 DIFFERENT TYPES OF NATURAL BIOSURGICAL SEALANTS
FIGURE 10 ASIA-PACIFIC BONE-GRAFT SUBSTITUTES MARKET BY SYNTHETIC GRAFT EXTENDERS 2019-2027 (IN $ MILLION)
FIGURE 11 ASIA-PACIFIC BONE-GRAFT SUBSTITUTES MARKET BY DEMINERALIZED BONE MATRIX 2019-2027 (IN $ MILLION)
FIGURE 12 ASIA-PACIFIC BONE-GRAFT SUBSTITUTES MARKET BY BONE MORPHOGENETIC PROTEINS 2019-2027 (IN $ MILLION)
FIGURE 13 ASIA-PACIFIC BONE-GRAFT SUBSTITUTES MARKET BY CELL-BASED MATRICES 2019-2027 (IN $ MILLION)
FIGURE 14 ASIA-PACIFIC BIOSURGERY MARKET BY HEMOSTATIC AGENTS 2019-2027 (IN $ MILLION)
FIGURE 15 ASIA-PACIFIC BIOSURGERY MARKET BY SOFT-TISSUE MANAGEMENT 2019-2027 (IN $ MILLION)
FIGURE 16 ASIA-PACIFIC BIOSURGERY MARKET IN SOFT-TISSUE MANAGEMENT 2019-2027 (IN $ MILLION)
FIGURE 17 ASIA-PACIFIC SOFT-TISSUE MANAGEMENT MARKET BY SYNTHETIC MESHES 2019-2027 (IN $ MILLION)
FIGURE 18 ASIA-PACIFIC BIOSURGERY MARKET BY SURGICAL SEALING AGENTS 2019-2027 (IN $ MILLION)
FIGURE 19 ASIA-PACIFIC SURGICAL SEALING AGENTS MARKET BY NATURAL 2019-2027 (IN $ MILLION)
FIGURE 20 ASIA-PACIFIC SURGICAL SEALING AGENTS MARKET BY SYNTHETIC 2019-2027 (IN $ MILLION)
FIGURE 21 ASIA-PACIFIC BIOSURGERY MARKET IN ANTI-ADHESIVE AGENTS 2019-2027 (IN $ MILLION)
FIGURE 22 ASIA-PACIFIC BIOSURGERY MARKET BY NEURO AND SPINE SURGERY 2019-2027 (IN $ MILLION)
FIGURE 23 ASIA-PACIFIC BIOSURGERY MARKET BY CARDIO AND THORACIC SURGERY 2019-2027 (IN $ MILLION)
FIGURE 24 ASIA-PACIFIC BIOSURGERY MARKET BY GENERAL SURGERY 2019-2027 (IN $ MILLION)
FIGURE 25 ASIA-PACIFIC BIOSURGERY MARKET BY ORTHOPEDIC SURGERY 2019-2027 (IN $ MILLION)
FIGURE 26 ASIA-PACIFIC BIOSURGERY MARKET BY NATURAL 2019-2027
FIGURE 27 ASIA-PACIFIC BIOSURGERY MARKET BY SYNTHETIC 2019-2027
FIGURE 28 ASIA-PACIFIC BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 29 CHINA BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 30 RATE OF GERIATRIC POPULATION STATISTICS, BY AGE IN JAPAN (%)
FIGURE 31 JAPAN BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 32 INDIA BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 33 AUSTRALIA BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 34 REST OF ASIA-PACIFIC BIOSURGERY MARKET 2019-2027 (IN $ MILLION)